TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05163288: A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

Sponsor: IntraBio Inc · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 53 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$2,592,920

Rescue Site Savings

+$1,697,184

Unlock Full NCT05163288 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05163288 Rescue Dossier →